Genome editing patent gets thumbs down by IP Australia
Ashurst
2018-09-19 8:58 pm
| Sydney
A patent for genome editing technology by a South Korean biotechnology company has been rejected for a lack of clarity, novelty, and inventiveness, but the Australian Patent Office has given the company two months to try again.
For information on rights and reprints, contact subscriptions@lawyerly.com.au